Background
==========

Bacterial pneumonia \[[@B1]\] and invasive pneumococcal disease \[[@B2]\] are closely associated with HIV infection but the mechanisms underlying this increased susceptibility are poorly understood. Bed-bound patients develop an altered pattern of tracheo-bronchial colonizing flora in almost all cases, and this is thought to be a risk factor for nosocomial infection \[[@B3]\]. We hypothesized that HIV infection might lead to an increase in bronchial and bronchiolar bacterial colonization, which would increase the risk of bacterial pneumonia in these patients.

Protected specimen brushing (PSB) is a bronchoscopic technique used for obtaining lower respiratory tract material without contamination from upper respiratory tract colonising bacteria \[[@B4]\]. We used this technique in healthy volunteer adults to determine the rates of bacterial colonisation at different sites in the respiratory tract and the association of pulmonary colonisation with HIV infection. The expected rates of bacterial colonisation were found in HIV uninfected adults with no increase in rate in HIV infected adults, even with low CD4 counts.

Methods
=======

Volunteers were recruited by advertisement in the Queen Elizabeth Central Hospital, Blantyre, Malawi. Healthy adults with normal chest radiographs were enrolled and tested for HIV using 2 rapid tests (HIV Serocard and HIV Gold, Trinity Biotech, Ireland). No subject had taken antibiotics within 2 weeks or any anti-retroviral medication.

Nasopharyngeal and oropharyngeal swabs were collected prior to bronchoscopy and directly inoculated on to blood agar plates. Bronchoscopy without sedation was carried out using topical lignocaine anaesthesia to the nasopharynx, larynx and trachea but not to the distal airways. After inspection to the carina only, a PSB catheter (Mill Rose microbiology brush, Keymed, UK) was directed in to the right middle lobe orifice. This catheter consists of an inner brush contained in a sterile sheath in turn itself contained within a wax-plugged outer sheath. The PSB catheter was passed to the point of mild resistance distally (at least 6 cm distal to the sub-segmental carina in the manner of a transbronchial biopsy) when the middle sheath and finally the sampling brush were advanced. After brushing, the brush was re-sheathed in reverse order, removed from the bronchoscope, re-extruded and the brush cut off into 10 ml of sterile saline. In the final 12 subjects, the PSB was directed to the distal right main bronchus (a much more proximal site and therefore likely to have more exposure to inhaled bacteria in all subjects) and sample collected as above followed by a 10 ml tracheal washing collected in a sputum trap. All samples were processed in the laboratory within 20 minutes of the bronchoscopy.

In the laboratory, investigators were kept unaware of the HIV status of the particular patients being studied. Blood agar plates inoculated with upper airway swabs were inspected after 24 hours incubation at 37°C in candle jars and sub-cultured colonies used to identify colonising organisms. All liquid samples (distal and proximal PSB samples and tracheal washings) were vortexed vigorously and the brush removed when present. The saline was then directly sampled (100 μl) on to culture plates (sheep blood agar, 15-lactose electrolyte-deficient (CLED), sabarose agar and chocolate blood agar) before being centrifuged and the residual pellet inoculated on to an identical set of plates. All plates were incubated for up to 5 days and cultured isolates were identified using standard methods including colony morphology, Gram stain, optochin sensitivity and coagulase testing.

The University of Malawi College of Medicine Research and Ethics Committee gave the study ethical approval and all volunteers gave written informed consent. A small remuneration approved by the Ethics Committee was given to all volunteers.

Results
=======

49 volunteers (37 male, mean age 34 yrs; 12 female, mean age 23 yrs) were studied of whom 27 were HIV infected. CD4 counts were lower in HIV infected subjects (mean CD4 count of 243 cells/ul, range 7--706) compared to HIV uninfected subjects (mean CD4 count 721 cells/ul, range 444--1198). The HIV infected group had a mean body mass index (BMI) of 19.8 kg/m^2^(range 14.7--25) which was lower than that of the HIV uninfected group (mean BMI 21.3 kg/m^2^; range 17.9--25.3; ranksum test p = 0.03).

The percentage of subjects showing colonisation by a typical colonising organism at the different sites sampled is shown in Figure [1](#F1){ref-type="fig"}, divided according to HIV status. All subjects demonstrated either nasal or oral colonization or both, with a progressive reduction in colonisation distally. The organisms identified were *Streptococcus viridans*, beta-haemolytic *Streptococcus spp., Streptococcus. pneumoniae, Staphylococcus aureus, Staphylococcus epidermidis*, diptheroids and a single isolate of *Aspergillus spp*. *Bacillus sp*. and micrococci were discarded as contaminants as they are not typical of nasopharngeal isolates. No *Neisseria meningitidis*or *Haemophilus influenzae*were recovered. Bacterial isolates were all obtained from the vortexed specimen except in 1 distal lung sample where only the pellet grew *Streptococcus sp*. and *Staphylococcus epidermidis*.

![**Bacterial colonisation of the airways by HIV status.**The figure shows the percentage of adults with bacterial colonisation of the oro-pharynx, posterior nasopharynx, trachea, right main bronchus and distal bronchi as measured using swabs (pharynx), tracheal washing and protected specimen brushing (right main bronchus and distal bronchi). Subjects are grouped according to HIV status and show no significant difference in percent colonisation at any site between HIV infected and non-HIV infected adults. The actual numbers of isolates are indicated over the bars and the bacteriological detail is included in the text.](1471-2334-3-29-1){#F1}

There was no significant difference in the proportion of subjects with bacterial colonization at any site when compared by HIV serostatus (see Figure [1](#F1){ref-type="fig"}) and the only bacteria obtained from distal airways were *Streptococcus viridans*and *Staphylococcus epidermidis*recovered from 2 non-HIV-infected subjects. Grouping the findings to compare the proportions of subjects with bacteria detected above or below the carina by HIV status showed no significant difference (HIV negative 3/22; HIV positive 3/27: χ^2^test p = 0.8) and the mean CD4 count of subjects with and without bacteria below the carina was not significantly different (472 cells/ul and 389 cells/ul; rank sum test p = 0.5)

*S. pneumoniae*were detected in nasal or oral swabs from 6/49 subjects (5 HIV negative; 1 HIV positive) and in all tracheal washings from subjects with nasopharyngeal *S. pneumoniae*. *S. pneumoniae*was not detected in any distal airway sample but was recovered from the right main bronchus PSB of one HIV positive subject (CD4 count of 125 cells/ul) in whom *Aspergillus spp*. was recovered from tracheal washings.

Discussion
==========

Using the PSB method, we obtained lower respiratory tract samples from HIV-infected and HIV uninfected adults. There were no bacteria recovered from the most distal airways of HIV infected adults, and equal numbers of bacteria in the right main bronchus of HIV infected and uninfected adults. Significant numbers of common nasal colonizing organisms were recovered from the proximal airways of HIV infected and uninfected adults. No relation was observed between bacterial colonisation and CD4 count. There was therefore no evidence of increased bacterial colonisation in the bronchi of HIV infected adults.

The PSB method may underestimate bacterial colonisation due to the small volume of sample collected. Our methods detected sufficient organisms in upper respiratory sites, however, that we are confident of the sterile results reported in the lower airway.

HIV infected adults have at least 10 times the incidence of bacterial pneumonia reported for age-matched non-HIV-infected adults \[[@B1],[@B2]\]. Using the rate of bacterial detection observed in the lower respiratory tract in non-HIV-infected adults (2/18), our hypothesis was that most HIV infected subjects might have an alteration of tracheo-bronchial flora as is the case in bed-bound patients \[[@B3]\]. This study had 90% power to show a 6 or more times increase in the rate of bacterial recovery from the lower respiratory tract of HIV infected adults (p = 0.05) but in the event there were no bacteria at all recovered from this site in the HIV infected group. We therefore reject the hypothesis that the increased rate of pneumonia seen in HIV infected adults might be due to increased colonization of the lower respiratory tract.

An important caveat of this finding, however, is that the colonisation of distal airways by *Streptococcus pneumoniae*was noted in only one subject and only as far as the right main bronchus. It is possible that HIV infected adults experience an increased rate of pneumococcal colonisation in the distal airways but the 6 patients with nasopharyngeal pneumococcal carriage in this study are insufficient to test this alternative hypothesis. In conclusion, therefore, there was no evidence of increased bacterial colonisation of the lower respiratory tract. Alternative explanations of the excess pneumococcal disease seen in otherwise healthy HIV infected patients must be sought, and vaccine strategies designed to enhance immune defences against the pattern of airway flora described in this study.
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